ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,238.00
0.03%
S&P 500
5,321.41
0.25%
US Dollar vs CAD
1.36555
0.11%
Bitcoin
69,909.21
-0.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vernalis Plc ADS (MM) (VNLS)

  7. Vernalis Plc ADS (MM) (VNLS) News

VNLS

Vernalis (VNLS)

Vernalis Plc ADS (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VNLS
DateTimeSourceHeadlineSymbolCompany
12/11/20061:00AMPR Newswire (US)Vernalis plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type IINASDAQ:VNLS
11/21/20061:00AMPR Newswire (US)Vernalis plc to Present at the 18th Annual Piper Jaffray Healthcare Conference in New York on November 30, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
11/20/20061:00AMPR Newswire (US)Vernalis plc Announces Progress on Its Oncology Hsp90 ProgrammeNASDAQ:VNLS
11/02/20061:00AMPR Newswire (US)Vernalis to Present at Cowen and Company 7th Annual Global Health Care ConferenceNASDAQ:VNLS
09/20/20068:31AMPR Newswire (US)Vernalis plc to Present at UBS Global Life Sciences Conference on September 26, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
09/20/20065:30AMPR Newswire (US)Vernalis plc Announces FDA Acceptance for Filing of Frova(R) for Short-Term Prevention of Menstrual MigraineNASDAQ:VNLS
09/12/20062:00AMPR Newswire (US)Vernalis Plc: Interim Results for the Six Months Ended 30 June 2006NASDAQ:VNLS
07/19/20065:00PMPR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLSVernalis Plc ADS (MM)
07/19/20065:00PMPR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLS
06/19/20066:00AMPR Newswire (US)Vernalis plc to Present at Investor Conferences During June 2006NASDAQ:VNLSVernalis Plc ADS (MM)
05/17/200612:00PMPR Newswire (US)Vernalis plc [VNLS] CEO to Ring the NASDAQ Stock Market Closing BellNASDAQ:VNLSVernalis Plc ADS (MM)
05/15/20062:00AMPR Newswire (US)Vernalis plc to Ring the NASDAQ Closing Bell on May 18, 2006NASDAQ:VNLS
05/08/20062:00AMPR Newswire (US)Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual MigraineNASDAQ:VNLS
07/14/20045:50PMPR Newswire (US)Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM)NASDAQ:VNLS
03/30/20046:00AMPR Newswire (US)Vernalis Regains Control of North American Rights To Frovatriptan From ElanNASDAQ:VNLSVernalis Plc ADS (MM)
03/30/20046:00AMPR Newswire (US)Vernalis plc: Preliminary Results for the Eight Months Ended 31 December 2003NASDAQ:VNLS
 Showing the most relevant articles for your search:NASDAQ:VNLS

Your Recent History

GATE
XWGUSDT
XWG
TSX
CARB
Global X Carbon Credits ...
EU
ENGBW
Engie Engie4.25%6sep34
NASDAQ
FWP
Forward Pharma AS
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved